Retinal Vein Occlusion Recruiting Phase 2 Trials for Aflibercept (DB08885)

Also known as: Occlusion Retinal Vein / Retinal-vein occlusion / Retinal Vein Occlusions(RVO) / Retinal Vein Occlusion (RVO) / Retinal Vein Occlusions

IndicationStatusPhase
DBCOND0000674 (Retinal Vein Occlusion)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02486484Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF InjectionTreatment